Protein Engineering Strategies for Improved Pharmacokinetics
Source abstract
Abstract
Abstract Protein therapeutics have gained momentum in recent years and become a pillar in treating many diseases and the only choice in several ailments. Protein therapeutics are highly specific, tunable, and less toxic than conventional small drug molecules. However, reaping the full benefits of therapeutic proteins in the clinics is often hindered by issues of immunogenicity and short half‐life due essentially to fast renal clearance and enzymatic degradation. Advances in polymer chemistry and protein engineering allowed overcoming some of these limitations. Strategies to prolong the half‐life of proteins rely on increasing their size and stability and/or fusing them to endogenous proteins (albumin, Fc fragment of antibody) to hijack physiological pathways involved in protein recycling. On the downside, these modifications might alter therapeutic proteins structure and function. Therefore, a compromise between half‐life and activity is sought. This review covers half‐life extension strategies using natural and synthetic polymers as well as fusion to other proteins and sheds light on genetic engineering strategies and chemical and enzymatic reactions to achieve this goal. Promising strategies and successful applications in the clinics are highlighted.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Protein purification and stability · Transgenic Plants and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Advanced Drug Delivery and Biomaterials Louvain Drug Research Institute Université catholique de Louvain (UCLouvain) Brussels 1200 Belgium
Center for Protein Engineering InBIOS Université de Liège 4000 Liège 1 Belgium
References (100+)
Show source-provided references
1. 10.1038/nbt.430510.1038/nbt.4305 ↗
2. 10.1038/nrd239910.1038/nrd2399 ↗
3. 10.1210/jc.2008-151810.1210/jc.2008-1518 ↗
4. 10.1038/s41573-018-0005-010.1038/s41573-018-0005-0 ↗
5. 10.1016/S0021-9258(17)40292-410.1016/S0021-9258(17)40292-4 ↗
6. 10.1007/978-1-4899-0703-510.1007/978-1-4899-0703-5 ↗
7. 10.1007/978-3-7643-8679-510.1007/978-3-7643-8679-5 ↗
8. 10.3389/fimmu.2020.0195110.3389/fimmu.2020.01951 ↗
9. 10.1158/1078-0432.CCR-19-297510.1158/1078-0432.CCR-19-2975 ↗
10. 10.1016/S0169-409X(03)00110-810.1016/S0169-409X(03)00110-8 ↗
11. 10.1200/JCO.2014.55.576310.1200/JCO.2014.55.5763 ↗
12. 10.1172/JCI11576110.1172/JCI115761 ↗
13. 10.1016/j.jconrel.2017.01.02910.1016/j.jconrel.2017.01.029 ↗
14. 10.1080/19420862.2016.118558110.1080/19420862.2016.1185581 ↗
15. 10.1016/S0169-409X(02)00026-110.1016/S0169-409X(02)00026-1 ↗
16. 10.1016/j.cocis.2017.08.00110.1016/j.cocis.2017.08.001 ↗
17. 10.1165/rcmb.486610.1165/rcmb.4866 ↗
18. 10.1016/j.ijpharm.2017.02.02110.1016/j.ijpharm.2017.02.021 ↗
19. 10.1016/j.jconrel.2014.05.02110.1016/j.jconrel.2014.05.021 ↗
20. 10.1002/adtp.20200014610.1002/adtp.202000146 ↗
21. Mahri S. · J. Controlled Release · 2020 · 10 · 1054
22. 10.1016/j.ijpharm.2020.12010710.1016/j.ijpharm.2020.120107 ↗
23. 10.1038/nbt81210.1038/nbt812 ↗
24. 10.1016/S1359-6446(05)03575-010.1016/S1359-6446(05)03575-0 ↗
25. 10.1530/EC-17-020310.1530/EC-17-0203 ↗
26. 10.1002/jbmr.382410.1002/jbmr.3824 ↗
27. 10.1124/jpet.119.25825110.1124/jpet.119.258251 ↗
28. 10.1021/bc07012310.1021/bc070123 ↗
29. 10.1016/j.ijpharm.2017.03.05710.1016/j.ijpharm.2017.03.057 ↗
30. 10.1021/mp500658w10.1021/mp500658w ↗
31. 10.1016/j.ijpharm.2008.01.01610.1016/j.ijpharm.2008.01.016 ↗
32. 10.1016/S0169-409X(03)00108-X10.1016/S0169-409X(03)00108-X ↗
33. 10.1002/jps.260083043210.1002/jps.2600830432 ↗
34. 10.1016/j.molimm.2008.08.27610.1016/j.molimm.2008.08.276 ↗
35. 10.1016/j.biomaterials.2012.09.00710.1016/j.biomaterials.2012.09.007 ↗
36. 10.1177/019262331559117110.1177/0192623315591171 ↗
37. 10.1021/bc000119x10.1021/bc000119x ↗
38. 10.1093/protein/gzt02310.1093/protein/gzt023 ↗
39. 10.1016/j.bmc.2017.09.01610.1016/j.bmc.2017.09.016 ↗
40. 10.1016/j.jconrel.2015.10.03810.1016/j.jconrel.2015.10.038 ↗
41. 10.1080/19420862.2015.111336010.1080/19420862.2015.1113360 ↗
42. 10.1016/B978-0-08-101750-0.00011-810.1016/B978-0-08-101750-0.00011-8 ↗
43. 10.1093/protein/gzm02010.1093/protein/gzm020 ↗
44. 10.1038/nbt.158810.1038/nbt.1588 ↗
45. 10.1371/journal.pone.001017510.1371/journal.pone.0010175 ↗
46. 10.1371/journal.pone.005063010.1371/journal.pone.0050630 ↗
47. 10.2967/jnumed.113.12810810.2967/jnumed.113.128108 ↗
48. 10.1021/bc500215m10.1021/bc500215m ↗
49. 10.1371/journal.pone.015719310.1371/journal.pone.0157193 ↗
50. 10.1002/jps.2322910.1002/jps.23229 ↗
51. 10.1210/jc.2015-327910.1210/jc.2015-3279 ↗
52. 10.1056/NEJMoa200269910.1056/NEJMoa2002699 ↗
53. 10.1182/blood.201900129210.1182/blood.2019001292 ↗
54. 10.1111/hae.1276610.1111/hae.12766 ↗
55. 10.1016/j.addr.2020.08.00810.1016/j.addr.2020.08.008 ↗
56. 10.1002/ijc.2090810.1002/ijc.20908 ↗
57. 10.1016/j.cocis.2017.06.00410.1016/j.cocis.2017.06.004 ↗
58. 10.1074/jbc.M114.60247410.1074/jbc.M114.602474 ↗
59. 10.1007/s00253-016-7944-310.1007/s00253-016-7944-3 ↗
60. 10.1007/s00125-016-4004-610.1007/s00125-016-4004-6 ↗
61. 10.1210/en.2015-151910.1210/en.2015-1519 ↗
62. 10.1021/mp500714710.1021/mp5007147 ↗
63. 10.2967/jnumed.116.17678410.2967/jnumed.116.176784 ↗
64. 10.4161/19420862.2014.98552210.4161/19420862.2014.985522 ↗
65. 10.2967/jnumed.114.14969010.2967/jnumed.114.149690 ↗
66. 10.1182/blood-2016-08-73280010.1182/blood-2016-08-732800 ↗
67. 10.1021/acs.bioconjchem.6b0036910.1021/acs.bioconjchem.6b00369 ↗
68. 10.1007/s10930-017-9699-910.1007/s10930-017-9699-9 ↗
69. 10.1002/bip.2306910.1002/bip.23069 ↗
70. 10.1016/S0021-9258(17)49941-810.1016/S0021-9258(17)49941-8 ↗
71. 10.1038/s41598-020-74549-010.1038/s41598-020-74549-0 ↗
72. 10.1080/21691401.2017.136942610.1080/21691401.2017.1369426 ↗
73. 10.1124/jpet.120.00001210.1124/jpet.120.000012 ↗
74. 10.1093/protein/gzz04710.1093/protein/gzz047 ↗
75. 10.7150/thno.3896810.7150/thno.38968 ↗
76. 10.1089/thy.2019.067010.1089/thy.2019.0670 ↗
77. 10.1007/s13139-020-00638-710.1007/s13139-020-00638-7 ↗
78. 10.1021/acs.biomac.5b0144610.1021/acs.biomac.5b01446 ↗
79. 10.1016/j.jconrel.2016.08.01010.1016/j.jconrel.2016.08.010 ↗
80. 10.1016/j.jconrel.2018.02.02510.1016/j.jconrel.2018.02.025 ↗
81. 10.1016/j.apmt.2019.10050110.1016/j.apmt.2019.100501 ↗
82. 10.1016/j.jconrel.2019.06.03010.1016/j.jconrel.2019.06.030 ↗
83. 10.1016/j.coph.2020.05.00410.1016/j.coph.2020.05.004 ↗
84. 10.1016/j.tibtech.2009.10.00410.1016/j.tibtech.2009.10.004 ↗
85. 10.1021/acs.biomac.8b0014710.1021/acs.biomac.8b00147 ↗
86. 10.1016/j.addr.2020.08.00810.1016/j.addr.2020.08.008 ↗
87. 10.1007/s13238-017-0457-810.1007/s13238-017-0457-8 ↗
88. 10.1111/j.1467-7652.2010.00523.x10.1111/j.1467-7652.2010.00523.x ↗
89. Toh W. H. · J. Cell Sci. · 2020 · 133
90. 10.1201/978131553324710.1201/9781315533247 ↗
91. 10.1002/bip.2309510.1002/bip.23095 ↗
92. Vidarsson G. · Front. Immunol. · 2014 · 110 · e23095
93. 10.1074/jbc.C30047020010.1074/jbc.C300470200 ↗
94. 10.4049/jimmunol.169.9.517110.4049/jimmunol.169.9.5171 ↗
95. 10.1074/jbc.M60429220010.1074/jbc.M604292200 ↗
96. 10.1182/blood-2017-12-82290810.1182/blood-2017-12-822908 ↗
97. 10.4049/jimmunol.179.8.557110.4049/jimmunol.179.8.5571 ↗
98. 10.2217/imt-2017-015510.2217/imt-2017-0155 ↗
99. A.Srivastava A. K.Brewer E. P.Mauser‐Bunschoten N. S.Key S.Kitchen A.Llinas C. A.Ludlam J. N.Mahlangu K.Mulder M. C.Poon A.Street 2013 19 e1.10.1111/j.1365-2516.2012.02909.x ↗
100. 10.1159/00048806010.1159/000488060 ↗